Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reply to «Glycaemic variability, a new concept of difficult control».

Revista clinica espanola·2016
Same author

[Evaluation of the effectiveness of a protocol designed to improve glycemic control in hospitalized internal medicine patients with hyperglycemia].

Anales del sistema sanitario de Navarra·2016
Same author

[Differential diagnosis of chronic back pain: A report of two cases].

Semergen·2015
Same author

[Illness and jaundice. Copalchi toxic hepatitis].

Semergen·2015
Same author

Anaphylaxis associated with the ingestion of Goji berries (Lycium barbarum).

Journal of investigational allergology & clinical immunology·2012
Same author

[Churg-Strauss syndrome associated with Wells syndrome].

Revista clinica espanola·2012

Related Experiment Videos

[Pneumonitis associated to methotrexate].

D Sáenz Abad1, F J Ruiz-Ruiz, S Monón Ballarín

  • 1Servicios de Urgencias, Hospital Clínico Universitario Lozano Blesa, Zaragoza. danielsaenzabad@hotmail.com

Anales De Medicina Interna (Madrid, Spain : 1984)
|April 2, 2008
PubMed
Summary
This summary is machine-generated.

Methotrexate (MTX) can cause lung damage, specifically acute interstitial pneumonitis. Early detection and treatment, including MTX withdrawal and corticosteroids, led to full recovery in a patient with autoimmune thrombocytopenia.

Related Experiment Videos

Area of Science:

  • Pulmonology
  • Rheumatology
  • Pharmacology

Background:

  • Methotrexate (MTX) is a folic acid antagonist used for its anti-inflammatory properties.
  • Acute interstitial pneumonitis is a known pulmonary complication of MTX therapy.

Observation:

  • A 56-year-old woman with autoimmune thrombocytopenia developed subacute cough, dyspnea, fever, and malaise.
  • Chest imaging revealed bilateral interstitial and alveolar infiltrates.
  • Infectious causes were excluded.

Findings:

  • Methotrexate-induced pneumonitis was diagnosed.
  • Discontinuation of MTX and initiation of methylprednisolone treatment resulted in progressive symptom improvement.
  • Complete resolution of clinical and radiological findings occurred within eight weeks.

Implications:

  • This case highlights the importance of recognizing MTX-induced pneumonitis in patients on MTX therapy.
  • Prompt diagnosis and management, including drug withdrawal and corticosteroid use, are crucial for favorable outcomes.
  • Awareness of this adverse effect is essential for clinicians managing patients with autoimmune diseases or receiving MTX for other indications.